American Hair Research Society Alopecia Areata Summit 2022

+ Target Audience: dermatologists, pediatric dermatologists, primary-care clinicians

+ Information:

A clinically oriented summit focused on the biology, diagnosis, and management of alopecia areata across ages and severities. Faculty translate emerging evidence—including targeted immunomodulation—into practical treatment pathways and longitudinal care plans.

What You Will Learn

• Pathophysiology and immunology of AA; phenotype spectrum and differential diagnosis

• Diagnostic workup: history/exam patterns, trichoscopy, labs when indicated, and biopsy pearls

• Treatment algorithms by severity and patient profile: topical/intralesional therapies, systemic options, and targeted agents

• Pediatric and adolescent considerations; pregnancy/lactation updates

• Managing comorbidities (atopy, autoimmunity, mood) and counseling for expectations

• Longitudinal care: relapse prevention, side-effect monitoring, and shared decision making

• Camouflage options, haircare counseling, and psychosocial support resources

Event Details

• Format: Case-based lectures, expert panels, and interactive Q&A with take-home checklists

• Structure: Biology/diagnostics → Therapeutics → Special populations → Long-term management & support

Who Should Attend
Dermatologists, pediatric dermatologists, primary-care clinicians with dermatology focus, NPs/PAs, residents/fellows, clinical researchers, and allied professionals supporting patients with hair disorders.

Why Attend

• Convert evolving evidence into clear, patient-centered treatment plans

• Improve safety and adherence with structured monitoring and education

• Enhance quality of life through integrated medical and psychosocial care

+ Topics:

• 22-AHRS-AA-Summit-Program-final-web-1-up
• Opening Session and Keynote
• Session 1 Setting the Stage of Basics of Alopecia Areata
• Session 2 JAK Inhibitors and Alopecia Areata
• Session 3 Lessons from JAK Inhibitors in Inflamatory Skin Diseases
• Session 4 Emerging Topics in Alopecia Areata
• Session 5 Integration of JAK Inhibitors into Clinical Practice